Larvol Delta - QPTORE004-A-Clinical-Study-Evaluating-a-Combination-of-Oregovomab-and-Niraparib-in-Adult-Women-With-Platinum-Sensitive-Recurrent-Ovarian-Cancer

Zejula (niraparib) - GSK, J&J

OvaRex (oregovomab) - CanariaBio

http://clinicaltrials.gov/ct2/show/NCT05335993

Jul 10, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next